ROCKVILLE, MD--(Marketwired - Apr 4, 2013) - MarketResearch.com has announced the addition of the market research report "Capitalizing on Opportunities in Cord Blood Industry Growth (2013 Version)" to their product offering.
Stem cells derived from umbilical blood have been used in more than 30,000 transplants worldwide to treat a wide range of blood diseases, genetic and metabolic disorders, immunodeficiencies and various forms of cancer. Additionally, cord blood banks now exist in nearly every developed country, as well as several developing nations. However, there is still significant variation within the industry.
First, there is the divide between private and public cord blood banking, in which private companies serve individual families, while public banks serve the broader public. Additionally, some cord blood banks receive only units from nearby hospitals and birthing centers, while others allow mail-in units from a wide geographic region. There is also variation in the services offered by private cord blood banks, with cord tissue storage emerging as a commercial service in 2010, when the Cord Blood Registry began offering it, to complement its cord blood banking services. This trend of cord tissue storage has had a significant impact on the cord blood banking industry, with nine private U.S. companies now offering the service. Finally, there is also significant variation in the quality, pricing, and guarantees promised by cord blood banks.
Despite this variation, as of 2013, the cord blood banking industry remains one of the fastest growing industries in the world. In 2005, there were only 23 active cord blood banks worldwide; today there are 485. This represents a 21-fold increase (2,100%) in industry growth, over only a seven year period.
Over the past 12 months alone, the cord blood banking industry has expanded through double digit growth, due to new entrants in the cord blood industry and revenue growth at existing operations. Deeper analysis reveals that most existing cord blood banks follow a bi-modal distribution, either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (25% or more per annum).
For more information, visit
Follow us on Facebook http://www.facebook.com/marketresearchdotcom
Follow us on Twitter http://www.twitter.com/marketresearch_
About BioInformant WorldWide, L.L.C.
BioInformant is the global leader in stem cell industry data. As a specialty research company, we use technology to track and identify profit opportunities in stem cell markets and provide this data to clients that require stem cell strategies. We advise companies on how to market stem cell products for immediate profit, competitively position products for additional profits within 1-3 months, and approach product development for dramatic long-term profits. Our clients acquire more stem cell customers within 30 days, using the strategies in our reports.
MarketResearch.com is the leading provider of global market intelligence products and services. With research reports from more than 720 top consulting and advisory firms, MarketResearch.com offers instant online access to the world's most extensive database of expert insights on global industries, companies, products, and trends. Moreover, MarketResearch.com's Research Specialists have in-depth knowledge of the publishers and the various types of reports in their respective industries and are ready to provide research assistance. For more information, call Cindy Frei at 240.747.3014 or visit http://www.marketresearch.com.